Last week, Abhijit Banerjee, Esther Duflo and Michael Kremer accepted the 2019 Nobel Memorial Prize in Economic Sciences. They were recognized for their use of randomized controlled trials, also known ...

The U.S. health care system is often inefficient, ineffective, and inequitable. Compared to other high-income countries, the U.S. pays more for health care and has worse outcomes. One potentially ...

Section 1115 waivers in the Medicaid program are meant to be experiments for states to test coverage approaches that don't meet federal requirements. However, most of those evaluations fall far short, ...

A new randomized, double-blind, sham-controlled clinical trial reports that a non-invasive, home-based light therapy produced measurable improvements in objective cognitive performance in adults under ...

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD Our results do not support a phase ...

Editor’s note: This story was first published on Econofact. The Nobel Memorial prize in Economic Sciences awarded this year to Abhijit Banerjee, Esther Duflo, and Michael Kremer has focused attention ...

Although we support Lisbeth B. Schorr’s call for a variety of evaluation methods to identify promising social programs (“Innovative Reforms Require Innovative Scorekeeping,” Aug. 26, 2009.), we ...

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First ...